Visit WTR Logo
Subscribe now

Law & Policy

No, pools should not be testing for validity

HEVC Advance counsel explains why the job of deciding whether a patent is valid or not is one for government agencies and courts, not licensing platforms

No, pools should not be testing for validity
Final call to take part in this year’s IAM benchmarking survey
26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market

Trade secrets not akin to property in India, says Delhi High Court
26 Mar 2020

Trade secrets not akin to property in India, says Delhi High Court

The recent decision highlights patchy protection in India and highlights potential pitfalls in know-how licensing

Latest

View all
25 Mar 2020

USPTO launches new diversity platform, but there is still much more for the IP community to do

Hub is designed to foster cooperation among stakeholders and to provide guidance on mentoring next generation of patent creators Read more

24 Mar 2020

Key takeaways from the Federal Circuit’s latest Arthrex decision

Judge Moore’s pragmatic approach holds, just about, as attention now turns to the prospects of Supreme Court granting cert Read more

24 Mar 2020

Covid-19 emergency may expose compulsory licensing limits

Government responses to the pandemic could include increased focus on obligatory sharing of patented inventions, but regulatory data exclusivities might serve as a barrier in both Europe and the United States. Read more

23 Mar 2020

In the fight against the coronavirus outbreak, life sciences companies need certainty in 101

An increase in R&D around the COVID-19 crisis could lead to a surge in innovation, but inventors will need to be sure what is patentable Read more

News

View all
19 Mar 2020

Final call for IP Hall of Fame 2020 nominations

You have until the end of the week to put forward names for consideration Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

17 Mar 2020

All IAM Covid-19 coverage to be free to view

As from today, all the features we run relating to the coronavirus pandemic will be put in front of our paywall Read more

16 Mar 2020

Donation is no defence to patent infringement in China

A company’s announced plans to give away a patented antiviral drug to treat Covid-19 would not protect it from infringement claims under Chinese law, but it could make a court less likely to award injunctive relief Read more

Analysis

View all
20 Mar 2020

German constitutional court rules country's accession to the UPC illegal

Decision focuses on process not principle, but the political reality is that the project is - for now, at least - dead Read more

19 Mar 2020

New CAFC Section 101 ruling creates pathway for protecting diagnostic-related methods

Although the majority decision is unexpected good news for innovators, it is likely to be challenged so uncertainty remains for now Read more

17 Mar 2020

How to secure IP litigation funding in the pharma and biotech sectors

Leading players in this evolving space tell IAM about trends in the biopharma industry and advise on how best to get investment Read more

13 Mar 2020

It’s one of the biggest jobs in private practice IP and one of the toughest acts to follow

New Fish & Richardson CEO,  John Adkisson, points to declining US litigation volumes as biggest challenge; but rise of global disputes one trend that looks set to continue Read more

Insights

View all
4 Mar 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in December, January and February. Read more

4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

29 Nov 2019

IP market news highlights

IAM’s biggest autumn reads Read more

29 Nov 2019

All eyes turn to London as UK Supreme Court mulls SEP FRAND cases

How the appeals brought by Huawei and ZTE could upend the licensing market Read more

Trending

1

The danger COVID-19 presents to biopharma patent owners

2

The impact of Covid-19 will be felt across the global IP market

3

All IAM Covid-19 coverage to be free to view

4

Covid-19 emergency may expose compulsory licensing limits

5

German constitutional court rules country's accession to the UPC illegal

Find an expert

Paul J Skiermont
Partner
Dallas, United States
Skiermont Derby LLP
View full biography
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.